“The approved pill for psoriasis distinguishes itself from other JAK inhibitors by being classified in a separate category called ‘selective TYK2 inhibitors,’” says Jeffrey Sobell, MD, a dermatologist at SkinCare Physicians in Chestnut Hill, Massachusetts. “This is the first and only medication that currently carries this designation.”

Congratulations!

You’ve learned a lot about JAK inhibitors for psoriasis. So, what’s next?

Take some extra time to absorb all this information and decide if a JAK inhibitor is something you might want to consider.

• Janus kinase (JAK) inhibitors are the first psoriasis treatment approved by the U.S. Food and Drug Administration.
• There are many considerations for anyone interested in taking JAK inhibitors, such as side effects and price.
• It’s essential to talk with your healthcare provider to know if JAK inhibitors are right for you.